Alvin S Parven - Net Worth and Insider Trading

Alvin S Parven Net Worth

The estimated net worth of Alvin S Parven is at least $1 Million dollars as of 2024-04-19. Alvin S Parven is the Director of Alexion Pharmaceuticals Inc and owns about 7,568 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $1 Million. Details can be seen in Alvin S Parven's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alvin S Parven has not made any transactions after 2017-06-15 and currently still holds the listed stock(s).

Transaction Summary of Alvin S Parven

To

Alvin S Parven Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alvin S Parven owns 1 companies in total, including Alexion Pharmaceuticals Inc () .

Click here to see the complete history of Alvin S Parven’s form 4 insider trades.

Insider Ownership Summary of Alvin S Parven

Ticker Comapny Transaction Date Type of Owner
Alexion Pharmaceuticals Inc 2017-06-15 director

Alvin S Parven Latest Holdings Summary

Alvin S Parven currently owns a total of 1 stock. Alvin S Parven owns 7,568 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 15, 2017, with a value of $1 Million.

Latest Holdings of Alvin S Parven

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2017-06-15 7,568 182.50 1,381,160

Holding Weightings of Alvin S Parven


Alvin S Parven Form 4 Trading Tracker

According to the SEC Form 4 filings, Alvin S Parven has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 835 shares on June 15, 2017, which brought Alvin S Parven around $97,511.

Insider Trading History of Alvin S Parven

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alvin S Parven Trading Performance

GuruFocus tracks the stock performance after each of Alvin S Parven's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alvin S Parven is -4.76%. GuruFocus also compares Alvin S Parven's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alvin S Parven within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alvin S Parven's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alvin S Parven

Average Return

29.41%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.27 -4.76 30.23 29.41 55.82 38.07
Relative Return to S&P 500(%) 6.57 -6.57 24.02 14.96 39.61 32.92

Alvin S Parven Ownership Network

Ownership Network List of Alvin S Parven

No Data

Ownership Network Relation of Alvin S Parven


Alvin S Parven Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Alvin S Parven is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Alvin S Parven Mailing Address

Above is the net worth, insider trading, and ownership report for Alvin S Parven. You might contact Alvin S Parven via mailing address: C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire Ct 06410.

Discussions on Alvin S Parven

No discussions yet.